agilon health’s (AGL) Sell Rating Reiterated at Citigroup

Citigroup reissued their sell rating on shares of agilon health (NYSE:AGL) in a research note released on Tuesday morning, Benzinga reports. They currently have a $2.50 target price on the stock, down from their prior target price of $7.00.

Several other equities research analysts have also weighed in on the company. Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research note on Wednesday, October 2nd. Benchmark reiterated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a research note on Thursday, August 8th. Royal Bank of Canada reiterated an “outperform” rating and issued a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Evercore ISI lowered their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Three analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $7.81.

agilon health Trading Down 6.7 %

Shares of AGL opened at $2.52 on Tuesday. agilon health has a 12-month low of $2.49 and a 12-month high of $18.37. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $1.04 billion, a price-to-earnings ratio of -3.60 and a beta of 0.54. The stock’s 50-day moving average price is $3.54 and its 200 day moving average price is $5.11.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.07). agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. The firm had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the previous year, the company posted ($0.04) earnings per share. The company’s quarterly revenue was up 38.7% compared to the same quarter last year. As a group, research analysts predict that agilon health will post -0.32 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 3.20% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Arizona State Retirement System lifted its stake in shares of agilon health by 2.5% in the 2nd quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock valued at $562,000 after purchasing an additional 2,070 shares during the period. Swiss National Bank lifted its stake in shares of agilon health by 0.6% in the 1st quarter. Swiss National Bank now owns 602,800 shares of the company’s stock valued at $3,677,000 after purchasing an additional 3,400 shares during the period. J.Safra Asset Management Corp lifted its stake in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the period. CWM LLC lifted its stake in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares during the period. Finally, Signaturefd LLC lifted its stake in shares of agilon health by 166.2% in the 2nd quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock valued at $77,000 after purchasing an additional 7,398 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.